Sponsors (31)
The bill secures dental and vision coverage plus oversight and federal guidance for Medicaid enrollees with sickle cell disease, improving care for that group while raising state costs and leaving non‑Medicaid patients without the same benefits.
Medicaid enrollees with sickle cell disease will gain guaranteed dental and vision coverage regardless of state comparability rules, improving access to oral and eye care.
State Medicaid programs, providers, and beneficiaries will gain stronger oversight and implementation support because states must report on quality, access, and expenditures for enrolled sickle cell patients and CMS will publish best practices by June 30, 2026.
State governments and taxpayers may face higher Medicaid costs to provide dental and vision benefits to this group, creating potential state budgetary pressure.
Uninsured and privately insured people with sickle cell disease will not receive the mandated dental and vision benefits, leaving coverage gaps and inequities.
Reporting requirements could divert time and resources from state agencies and providers if the Secretary's measures are burdensome or states decline to submit strong outcome data.
Based on analysis of 2 sections of legislative text.
Allows Medicaid health home amendments focused on people with sickle cell disease starting Jan 1, 2026, requires dental/vision for those enrollees, and mandates outcome-focused reporting and CMS best practices.
Introduced September 8, 2025 by Neal Patrick Dunn · Last progress September 8, 2025
Allows states to create Medicaid health home State plan amendments that focus specifically on people with sickle cell disease beginning January 1, 2026. States that adopt an approved sickle cell disease-focused amendment must provide dental and vision services to eligible enrollees with sickle cell disease regardless of whether those benefits are provided to other Medicaid beneficiaries, submit outcome-focused reports to HHS on quality, access, and expenditures, and follow CMS guidance and measures. CMS must publish best practices by June 30, 2026 based on clinical guidelines and stakeholder input.